Literature DB >> 28846107

Nuclear factor E2-related factor-2 has a differential impact on MCT1 and MCT4 lactate carrier expression in colonic epithelial cells: a condition favoring metabolic symbiosis between colorectal cancer and stromal cells.

K Diehl1, L-A Dinges2, O Helm2, N Ammar2, D Plundrich2, A Arlt1, C Röcken3,4, S Sebens2,4, H Schäfer1,2.   

Abstract

Malignant tumors, such as colorectal cancer (CRC), are heterogeneous diseases characterized by distinct metabolic phenotypes. These include Warburg- and reverse Warburg phenotypes depending on differential distribution of the lactate carrier proteins monocarboxylate transporter-4 and -1 (MCT4 and MCT1). Here, we elucidated the role of the antioxidant transcription factor nuclear factor E2-related factor-2 (Nrf2) as the key regulator of cellular adaptation to inflammatory/environmental stress in shaping the metabolism toward a reverse Warburg phenotype in malignant and premalignant colonic epithelial cells. Immunohistochemistry of human CRC tissues revealed reciprocal expression of MCT1 and MCT4 in carcinoma and stroma cells, respectively, accompanied by strong epithelial Nrf2 activation. In colorectal tissue from inflammatory bowel disease patients, MCT1 and Nrf2 were coexpressed as well, relating to CD68+inflammatory infiltrates. Indirect coculture of human NCM460 colonocytes with M1- but not M2 macrophages induces MCT1 as well as G6PD, LDHB and TALDO expression, whereas MCT4 expression was decreased. Nrf2 knockdown or reactive oxygen species (ROS) scavenging blocked these coculture effects in NCM460 cells. Likewise, Nrf2 knockdown inhibited similar effects of tBHQ-mediated Nrf2 activation on NCM460 and HCT15 CRC cells. M1 coculture or Nrf2 activation/overexpression greatly altered the lactate uptake but not glucose uptake and mitochondrial activities in these cells, reflecting the reverse Warburg phenotype. Depending on MCT1-mediated lactate uptake, Nrf2 conferred protection from TRAIL-induced apoptosis in NCM460 and HCT15 cells. Moreover, metabolism-dependent clonal growth of HCT15 cells was induced by Nrf2-dependent activation of MCT1-driven lactate exchange. These findings indicate that Nrf2 has an impact on the metabolism already in premalignant colonic epithelial cells exposed to inflammatory M1 macrophages, an effect accompanied by growth and survival alterations. Favoring the reverse Warburg effect, these Nrf2-dependent alterations add to malignant transformation of the colonic epithelium.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28846107     DOI: 10.1038/onc.2017.299

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  70 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 2.  Metabolic targets for cancer therapy.

Authors:  Lorenzo Galluzzi; Oliver Kepp; Matthew G Vander Heiden; Guido Kroemer
Journal:  Nat Rev Drug Discov       Date:  2013-10-11       Impact factor: 84.694

Review 3.  Emerging avenues linking inflammation and cancer.

Authors:  Joydeb Kumar Kundu; Young-Joon Surh
Journal:  Free Radic Biol Med       Date:  2012-03-03       Impact factor: 7.376

4.  Role of the lactate transporter (MCT1) in skeletal muscles.

Authors:  K J McCullagh; R C Poole; A P Halestrap; M O'Brien; A Bonen
Journal:  Am J Physiol       Date:  1996-07

5.  Evidence for a stromal-epithelial "lactate shuttle" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts.

Authors:  Diana Whitaker-Menezes; Ubaldo E Martinez-Outschoorn; Zhao Lin; Adam Ertel; Neal Flomenberg; Agnieszka K Witkiewicz; Ruth C Birbe; Anthony Howell; Stephanos Pavlides; Ricardo Gandara; Richard G Pestell; Federica Sotgia; Nancy J Philp; Michael P Lisanti
Journal:  Cell Cycle       Date:  2011-06-01       Impact factor: 4.534

6.  Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma.

Authors:  Michael I Koukourakis; Alexandra Giatromanolaki; Adrian L Harris; Efthimios Sivridis
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

Review 7.  Metabolic interplay between glycolysis and mitochondrial oxidation: The reverse Warburg effect and its therapeutic implication.

Authors:  Minjong Lee; Jung-Hwan Yoon
Journal:  World J Biol Chem       Date:  2015-08-26

8.  Keap1/Nrf2 pathway activation leads to a repressed hepatic gluconeogenic and lipogenic program in mice on a high-fat diet.

Authors:  Stephen L Slocum; John J Skoko; Nobunao Wakabayashi; Susan Aja; Masayuki Yamamoto; Thomas W Kensler; Dionysios V Chartoumpekis
Journal:  Arch Biochem Biophys       Date:  2015-12-14       Impact factor: 4.013

9.  Oncometabolic Nuclear Reprogramming of Cancer Stemness.

Authors:  Javier A Menendez; Bruna Corominas-Faja; Elisabet Cuyàs; María G García; Salvador Fernández-Arroyo; Agustín F Fernández; Jorge Joven; Mario F Fraga; Tomás Alarcón
Journal:  Stem Cell Reports       Date:  2016-02-11       Impact factor: 7.765

Review 10.  Cytoprotection "gone astray": Nrf2 and its role in cancer.

Authors:  Claudia Geismann; Alexander Arlt; Susanne Sebens; Heiner Schäfer
Journal:  Onco Targets Ther       Date:  2014-08-26       Impact factor: 4.147

View more
  14 in total

Review 1.  Non-canonical roles for metabolic enzymes and intermediates in malignant progression and metastasis.

Authors:  Demond Williams; Barbara Fingleton
Journal:  Clin Exp Metastasis       Date:  2019-05-09       Impact factor: 5.150

Review 2.  Metabolite transporters as regulators of macrophage polarization.

Authors:  Jingwen Cheng; Weiwei Cai; Shiye Zong; Yun Yu; Fang Wei
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-12-01       Impact factor: 3.000

Review 3.  Exosomes as Theranostic Targets: Implications for the Clinical Prognosis of Aggressive Cancers.

Authors:  Richa Gulati; Dhruva Nandi; Koustav Sarkar; P Venkataraman; K M Ramkumar; Priya Ranjan; Rajiv Janardhanan
Journal:  Front Mol Biosci       Date:  2022-06-23

Review 4.  Monocarboxylate Transporters (SLC16): Function, Regulation, and Role in Health and Disease.

Authors:  Melanie A Felmlee; Robert S Jones; Vivian Rodriguez-Cruz; Kristin E Follman; Marilyn E Morris
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

Review 5.  How Dysregulated Ion Channels and Transporters Take a Hand in Esophageal, Liver, and Colorectal Cancer.

Authors:  Christian Stock
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

6.  Downregulation of MCT4 for lactate exchange promotes the cytotoxicity of NK cells in breast carcinoma.

Authors:  Yaping Long; Zihe Gao; Xiao Hu; Feng Xiang; Zhaozhen Wu; Jiahui Zhang; Xiao Han; Liyong Yin; Junfang Qin; Lan Lan; Fuzai Yin; Yue Wang
Journal:  Cancer Med       Date:  2018-07-26       Impact factor: 4.452

7.  Protective effects of novel derivatives of vitamin D3 and lumisterol against UVB-induced damage in human keratinocytes involve activation of Nrf2 and p53 defense mechanisms.

Authors:  Anyamanee Chaiprasongsuk; Zorica Janjetovic; Tae-Kang Kim; Stuart G Jarrett; John A D'Orazio; Michael F Holick; Edith K Y Tang; Robert C Tuckey; Uraiwan Panich; Wei Li; Andrzej T Slominski
Journal:  Redox Biol       Date:  2019-04-20       Impact factor: 11.799

8.  Inflammation Associated Pancreatic Tumorigenesis: Upregulation of Succinate Dehydrogenase (Subunit B) Reduces Cell Growth of Pancreatic Ductal Epithelial Cells.

Authors:  Sascha Rahn; Philippe Dänzer Barbosa; Julia Luisa Möller; Nourhane Ammar; Tobias Demetrowitsch; Ole Helm; Daniela Wesch; Bence Sipos; Christoph Röcken; Karin Schwarz; Heiner Schäfer; Susanne Sebens
Journal:  Cancers (Basel)       Date:  2019-12-21       Impact factor: 6.639

Review 9.  Development of targeted therapy of NRF2high esophageal squamous cell carcinoma.

Authors:  Chorlada Paiboonrungruang; Emily Simpson; Zhaohui Xiong; Caizhi Huang; Jianying Li; Yahui Li; Xiaoxin Chen
Journal:  Cell Signal       Date:  2021-08-04       Impact factor: 4.850

10.  miR-1269 promotes cell survival and proliferation by targeting tp53 and caspase-9 in lung cancer.

Authors:  Min Bao; Yingjian Song; Jingjing Xia; Pengling Li; Qing Liu; Zongren Wan
Journal:  Onco Targets Ther       Date:  2018-03-26       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.